Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.27B
Enterprise Value5.26B
P/E Ratio76.02
PEG Ratio-1.04
Price/Sales Ratio2.79
Price/Book Ratio1.06
Enterprise/Revenue2.75
Enterprise/EBITDA18.81

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.04
Operating Margin-0
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue1.73B
Revenue/Share1.41
Gross Profit563.3M
EBITDA312.47M
Net Income77M
Diluted EPS0.06

Balance Sheet

Total Cash919.63M
Total Cash/Share0.77
Total Debt696.16M
Total Debt/Equity0.16
Current Ratio2.25
Book Value Per Share3.72

Price History

52-Week Change-18.8
52-Week High5
52-Week Low3.24
Moving Average 50 Days3.7
Moving Average 200 Days4.15

Statistics

Average Volume17.51M
Shares Outstanding1.19B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.07
Trailing Annual Dividend Yield1.78
Payout Ratio2.42
Last Split Factor3:1
Last Split DateMay 10, 2017
AD